"Daptomycin, Fibonacci Numbers, and the Golden Ratio: A Brief First Numerical Observation" by Stefan A. Geier et al.

 Daptomycin, Fibonacci Numbers, and the Golden Ratio: A Brief First Numerical Observation

by Stefan A. Geier*, Caroline Geier, Stephanie Geier, Constantin Geier, Katharina Geier,
Nora Blättermann-Goldstein, and Michèle Geier-Noehl**

Institute for Structuralistic Theory of Sciences Simssee (ISTS), Gerhart-Hauptmann-Straße 6, 83071 Haidholzen, Germany; and Ludwig-Maximilians-Universität Munich, Germany.
**Dermatologische Klinik der Landeshauptstadt und der Ludwig-Maximilians-Universität LMU München, Thalkirchner Straße 48, 80337 Munich, Germany.
*Correspondence: Stefan A. Geier; wissenschaftstheorie.simssee.1@gmail.com

Abstract

Daptomycin contains 13 amino acid residues, an exact Fibonacci number, and has a reported molar mass of 1620.67 g/mol. Its decimal significand, 1.62067, differs from the golden ratio by approximately 0.163%. These numerical correspondences are described without assuming biological causation or statistical significance.

Keywords: daptomycin; Fibonacci numbers; Geier programme; golden ratio; amino acid count; molecular mass

Introduction

During a kitchen table discussion this Sunday of Staphylococcus aureus sepsis and its treatment, we highlighted daptomycin as a valuable antibiotic for S. aureus bloodstream infections, including those caused by methicillin-resistant strains. Its clinical efficacy in bacteremia and right-sided endocarditis has been demonstrated in a randomized trial [1]. Examining its molecular composition subsequently drew our attention to two numerical correspondences involving Fibonacci numbers and the golden ratio. 

Methods and Results

We examined daptomycin’s established chemical structure and the molecular-weight value reported in its prescribing information [2].

Amino acid count. Daptomycin is a cyclic lipopeptide comprising 13 amino acid residues, with ten residues forming the macrocyclic portion and three constituting an exocyclic peptide chain. Thus, its total residue count is exactly a Fibonacci number: \(F_7=13\), using the convention \(F_0=0\) and \(F_1=1\). The actual structural partition is \(10+3\), rather than the Fibonacci decomposition \(8+5\). 

Molar mass. For daptomycin’s molecular formula, C₇₂H₁₀₁N₁₇O₂₆, the prescribing information reports a molecular weight corresponding to a molar mass of 1620.67 g/mol [2]. In scientific notation:

\[ M=1.62067\times10^3\ \mathrm{g\,mol^{-1}}. \]

Its decimal significand, \(s=1.62067\), was compared with the golden ratio,

\[ \varphi=\frac{1+\sqrt5}{2}=1.6180339887\ldots \]

The calculated relative deviation is

\[ \delta=\frac{|s-\varphi|}{\varphi}\times100 =\mathbf{0.162914\%\approx0.163\%}. \]

The deviation of the significand from Phi is less than 0.2%.

Discussion and Conclusion

Daptomycin therefore exhibits an exact Fibonacci residue count and an approximate correspondence between its decimal mass significand and the golden ratio. The latter concerns a numerical representation of mass, not a demonstrated geometric ratio within the molecule.

Neither observation, individually or together, establishes a biological mechanism, explains antibiotic activity, or demonstrates enrichment beyond chance. Evaluating their broader significance would require an independently selected dataset of peptide antibiotics, predefined comparison rules, and an appropriate statistical null model. The present report documents a numerical observation rather than evidence of a Fibonacci- or golden-ratio-based biological law. However, in the Geier Programme context the presented obeservation supports Geier's equations and Geier's equilibrium concept.

References

1. Fowler VG Jr, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. New England Journal of Medicine. 2006;355:653–665. doi:10.1056/NEJMoa053783.

2. U.S. Food and Drug Administration. Daptomycin for Injection: Prescribing Information. 2025. Section 11, Description, p. 19.
   
   
   

Figure:

Description	English: Skeletal formula of daptomycin. Created using ACD/ChemSketch 10.0 and Inkscape.
Date	24 August 2008
Source	Own work based on: Structure of Daptomycin.gif and Ball, LJ; Goult CM; Donarski JA; Micklefield J; Ramesh V (2008-08-24). "NMR structure determination and calcium binding effects of lipopeptide antibiotic daptomycin". Org. Biomol. Chem. 2 (13): 1872–8. PMID 15227539. doi:10.1039/b402722a
Author	Fvasconcellos

xxxxxxx  Extended version 12.10.2026; open for discussion and improvement  xxxxxxx

Daptomycin, Fibonacci Numbers, and the Golden Ratio

Molecular Composition, Numerical Correspondence, and a Framework for Systematic Evaluation

Descriptive molecular analysis and hypothesis-generating perspective

by Stefan A. Geier*, Caroline Geier, Stephanie Geier, Constantin Geier, Katharina Geier,
Nora Blättermann-Goldstein, and Michèle Geier-Noehl**

Institute for Structuralistic Theory of Sciences Simssee (ISTS), Gerhart-Hauptmann-Straße 6, 83071 Haidholzen, Germany; and Ludwig-Maximilians-Universität Munich, Germany.
**Dermatologische Klinik der Landeshauptstadt und der Ludwig-Maximilians-Universität LMU München, Thalkirchner Straße 48, 80337 Munich, Germany.
*Correspondence: Stefan A. Geier; wissenschaftstheorie.simssee.1@gmail.com

Abstract

Daptomycin is an established antibiotic for Staphylococcus aureus bloodstream infections, including infections caused by methicillin-resistant strains. A clinical discussion of its therapeutic value prompted examination of two numerical features of its molecular composition: its amino acid count and its molecular-mass significand. Daptomycin contains 13 amino acid residues, corresponding exactly to the Fibonacci number \(F_7\) under the convention \(F_0=0\), \(F_1=1\). Its reported molar mass of 1620.67 g/mol has the decimal significand 1.62067, which exceeds the golden ratio, \(\varphi=(1+\sqrt{5})/2\), by approximately 0.162914%. The molecule comprises a ten-residue macrocycle, a three-residue exocyclic segment, and an N-terminal decanoyl group; it does not exhibit an established structural partition of eight and five residues. A sensitivity calculation using the reported monoisotopic mass yields a deviation of approximately 0.103606%, showing that numerical proximity is not confined to the average-mass convention. These observations are reproducible but differ in evidential character: Fibonacci membership is an exact integer property, whereas golden-ratio proximity concerns a normalized numerical representation. Neither establishes biological causation or statistical enrichment. We describe the molecular basis of the observations and propose a comparative framework incorporating independent compound selection, explicit mass conventions, biosynthetically informed controls, and validation in a separate dataset.

Keywords: daptomycin; Staphylococcus aureus; cyclic lipopeptide; nonribosomal peptide; Fibonacci numbers; golden ratio; molecular mass; numerical correspondence

One-sentence summary: Daptomycin has an exact Fibonacci residue count and a decimal mass significand close to the golden ratio, providing a clearly defined observation for comparative investigation rather than an established biological law.

1. Introduction

During a discussion of Staphylococcus aureus sepsis and its treatment, our attention turned to daptomycin as a valuable antibiotic for bloodstream infections, including those caused by methicillin-resistant S. aureus (MRSA). Its clinical role is supported by a randomized trial demonstrating noninferiority to the study’s standard-therapy regimen for S. aureus bacteremia and right-sided endocarditis [1]. Examination of its molecular composition subsequently drew our attention to two numerical correspondences: its 13 amino acid residues constitute a Fibonacci number, and the decimal significand of its reported molecular weight lies close to the golden ratio [2,3].

These observations concern different properties. Residue count is an integer characteristic of molecular constitution. By contrast, a mass significand is obtained by expressing a mass value in a specified unit and numerical base. Accordingly, an exact match between a residue count and a Fibonacci number should be distinguished from approximate agreement between a normalized mass and an irrational mathematical constant.

Daptomycin is particularly suitable for a transparent examination because its chemical structure and biosynthetic machinery are well characterized [2,3]. Its modular nonribosomal synthesis and experimentally investigated analogues also provide a biological context in which proposed numerical relationships could eventually be assessed [3,4].

The present paper documents the two correspondences, states the calculations explicitly, and considers their interpretation. Its purpose is neither to infer antibiotic potency from number sequences nor to dismiss an observation solely because its biological meaning is unknown. Rather, it separates established molecular facts, derived numerical results, and hypotheses requiring additional evidence.

2. Materials and Methods

2.1. Study scope and molecular data

This is a source-based analysis of one previously characterized compound, not a new clinical trial or experimental chemistry study. The regulatory description supplied the molecular formula, chemical identity, and reported molecular-weight value [2]. Primary biosynthetic research was used to verify the 13-residue organization and stereochemical assignment, with related engineering studies providing additional structural context [3,4]. The PubChem record for daptomycin, CID 21585658, supplied a monoisotopic-mass value for sensitivity analysis [5].

The analyzed entity is the parent daptomycin molecule. Formulation ingredients, counterions, solvent molecules, calcium-bound species, and oligomeric assemblies are not included in the stated mass. The fatty-acyl group contributes to molecular mass but is not counted as an amino acid residue. The unit of observation is one molecular species; its 13 residues are not 13 independent observations of the proposed correspondence.

2.2. Fibonacci membership

The Fibonacci sequence was defined by

\[ F_0=0,\qquad F_1=1,\qquad F_{n+2}=F_{n+1}+F_n. \]

Its initial terms are

\[ 0,1,1,2,3,5,8,13,21,34,\ldots \]

Membership was evaluated by direct integer comparison with the total residue count. No tolerance interval, transformation of the residue count, or approximate sequence membership was required.

2.3. Decimal significand and relative deviation

The reported average molar mass was taken as \(M=1620.67\ \mathrm{g\,mol^{-1}}\) [2]. Define its numerical value in the specified unit as

\[ x=\frac{M}{1\ \mathrm{g\,mol^{-1}}}. \]

For positive \(x\), the normalized decimal significand is

\[ s_{10}(x)= \frac{x}{10^{\lfloor\log_{10}x\rfloor}}, \qquad 1\leq s_{10}<10. \]

Thus, \(s_{10}=1.62067\). The term significand denotes the leading coefficient in scientific notation and avoids ambiguity associated with the word mantissa.

The golden ratio and the percentage deviation were defined as

\[ \varphi=\frac{1+\sqrt5}{2} =1.6180339887498948\ldots, \]\[ D_\varphi(s)=100\frac{|s-\varphi|}{\varphi}. \]

The same normalization and deviation formula were applied to the numerical value of monoisotopic molecular mass expressed in daltons. Calculations retained additional digits internally; reported precision reflects a numerical comparison, not a new high-precision mass measurement.

2.4. Scope of statistical interpretation

No inferential significance test was performed. A percentage deviation is a distance measure, not a probability of chance occurrence. Estimating such a probability would require a defined population of eligible compounds, a sampling or selection model, and a justified distribution of residue counts and mass significands. None is supplied by a single molecular example.

3. Results

3.1. Residue composition and molecular architecture

Daptomycin contains the following 13 amino acid residues, listed in peptide sequence order [2–4].

Table 1. Amino acid composition of daptomycin.

Position	Residue	Structural location
1	L-Tryptophan (Trp)	Exocyclic segment
2	D-Asparagine (D-Asn)	Exocyclic segment
3	L-Aspartic acid (Asp)	Exocyclic segment
4	L-Threonine (Thr)	Macrocycle
5	Glycine (Gly)	Macrocycle
6	L-Ornithine (Orn)	Macrocycle
7	L-Aspartic acid (Asp)	Macrocycle
8	D-Alanine (D-Ala)	Macrocycle
9	L-Aspartic acid (Asp)	Macrocycle
10	Glycine (Gly)	Macrocycle
11	D-Serine (D-Ser)	Macrocycle
12	(2S,3R)-3-Methylglutamic acid (3-MeGlu)	Macrocycle
13	L-Kynurenine (Kyn)	Macrocycle

The 3-MeGlu residue is also designated threo-3-methyl-L-glutamic acid. Glycine is achiral.

Residues 4–13 form the cyclic portion through an ester linkage between the side-chain hydroxyl group of Thr4 and the terminal carboxyl group of Kyn13. Residues 1–3 form the exocyclic peptide segment, and a decanoyl group is attached to the N-terminal tryptophan [2,4]. Accordingly,

\[ N_{\mathrm{total}} =N_{\mathrm{ring}}+N_{\mathrm{exocyclic}} =10+3=13. \]

The residue inventory contains three aspartic-acid residues and two glycines; each of the other eight residue identities occurs once. Thus, 13 residues represent ten distinct amino acid identities. The D-configured residues occupy positions 2, 8, and 11 (All three Fibonacci or Lucas numbers.). The D-Asn assignment is important because primary biosynthetic and chemical work corrected an earlier L-Asn assignment [3].

3.2. Exact Fibonacci correspondence

The total residue count satisfies

\[ \boxed{N_{\mathrm{total}}=13=F_7.} \]

This correspondence is exact and requires no rounding. Although \(13=8+5\) is the relevant Fibonacci recurrence, the arithmetic decomposition must not be mistaken for daptomycin’s established structural organization. Its ring–exocyclic partition is \(10+3\), not \(8+5\).

The distinction also applies to biosynthesis. The three nonribosomal peptide synthetase subunits DptA, DptBC, and DptD are assigned five, six, and two residue-incorporating modules, respectively [3]. Their total is again 13, but the assembly-line partition is \(5+6+2\). Agreement between the total module count and the product’s residue count reflects their biosynthetic relationship; it is not an independent second example of Fibonacci enrichment.

3.3. Molecular mass and golden-ratio proximity

For the molecular formula \(\mathrm{C_{72}H_{101}N_{17}O_{26}}\), the regulatory description reports a molecular weight corresponding, at the stated precision, to a molar mass of 1620.67 g/mol [2]. Consequently,

\[ M=1.62067\times10^3\ \mathrm{g\,mol^{-1}}. \]

The absolute significand difference is

\[ s_{10}-\varphi =0.002636011250105\ldots, \]

and the relative deviation is

\[ \boxed{ D_\varphi =0.162914454729\ldots\% \approx0.163\%. } \]

For comparison, a mass with a decimal significand exactly equal to \(\varphi\) at the same order of magnitude would be

\[ M_\varphi =1000\varphi\ \mathrm{g\,mol^{-1}} =1618.033988749895\ldots\ \mathrm{g\,mol^{-1}}. \]

The difference from the reported daptomycin molar mass is therefore approximately \(2.63601\ \mathrm{g\,mol^{-1}}\).

Both 1.62067 and \(\varphi\) round to 1.62 at three significant figures. This provides a simple expression of their numerical proximity, but does not imply exact equality.

3.4. Sensitivity to mass convention and rounding

PubChem reports a computed monoisotopic molecular mass of 1619.71036639 Da [5]. Normalization gives \(s_{10}=1.61971036639\) and \(D_\varphi=0.103605835957\ldots\%\).

Table 2. Numerical comparison under explicitly identified mass conventions.

Quantity	Mass value and unit	Decimal significand	Deviation from \(\varphi\)
Reported average molar mass [2]	1620.67 g/mol	1.62067	0.162914%
Same value rounded to one decimal place	1620.7 g/mol	1.6207	0.164769%
Computed monoisotopic molecular mass [5]	1619.71036639 Da	1.61971036639	0.103606%

Average molar mass and monoisotopic molecular mass describe different quantities. Their numerical significands are compared separately under the specified units.

Proximity therefore persists in these representations, although its magnitude changes with mass convention. This sensitivity calculation is not independent biological replication: both mass values refer to the same chemical formula. The lower monoisotopic deviation should not replace the original average-mass result merely because it is numerically more favorable.

4. Discussion

4.1. What the observations establish

The first result establishes that the residue count belongs to the Fibonacci sequence. It does not establish that a Fibonacci recurrence generated the molecule or selected its length. Demonstrating such a process would require evidence beyond one integer membership relation, such as a quantitatively specified mechanism or a reproducible pattern across independently selected molecular families.

The mathematical connection between Fibonacci numbers and the golden ratio is nevertheless exact:

\[ \lim_{n\to\infty} \left(\frac{F_{n+1}}{F_n}\right) =\varphi. \]

This identity explains why the two mathematical objects are naturally discussed together. It does not make every Fibonacci-sized molecule a golden-ratio structure. For example, \(13/8=1.625\) is a ratio of neighboring Fibonacci numbers, not a measured ratio between identified components of daptomycin.

The second result establishes a small relative distance between the specified decimal mass significand and \(\varphi\). It does not identify a golden ratio between molecular dimensions, bond lengths, energetic states, or binding constants. Those would be distinct physical hypotheses requiring their own measurements and predictions.

4.2. Numerical representation and invariance

The mass comparison is explicitly normalized. Equating a dimensional mass directly with the dimensionless number \(\varphi\) would be inappropriate; the calculation instead compares \(\varphi\) with the dimensionless numerical coefficient obtained under a stated convention.

A useful nuance is that the decimal significand is invariant under multiplication by an integer power of ten:

\[ s_{10}(10^k x)=s_{10}(x), \qquad k\in\mathbb{Z}. \]

Thus, changing from g/mol to kg/mol does not eliminate the reported correspondence. Likewise, a molecular mass expressed in Da or kDa retains the same normalized decimal significand. However, arbitrary nondecimal rescaling or a change of numerical base need not preserve it.

The finding should therefore be described as a base-10 correspondence under conventional chemical mass units, rather than either a fully representation-independent law or an effect that disappears under every unit conversion.

4.3. Why residue count and mass are not independent

Daptomycin’s mass is determined by the same chemical constitution that determines its residue count. Formal stoichiometric accounting gives

\[ M_{\mathrm{DAP}} = \sum_{j=1}^{13}M_{j,\mathrm{free}} + M_{\mathrm{decanoic\ acid}} - 14M_{\mathrm{H_2O}}. \]

Here, the subtraction accounts formally for 12 peptide linkages between amino acid residues, one N-terminal fatty-acyl amide linkage, and one ring-closing ester linkage. This is molecular-formula bookkeeping from the established connectivity [2,4], not a description of every enzymatic reaction in nonribosomal synthesis.

Residue number, residue identities, lipid composition, and cyclization therefore jointly determine mass. A future joint analysis must account for this dependence rather than multiplying two nominal chance probabilities as though the observations were unrelated.

Furthermore, the two descriptors do not specify sequence order or stereochemistry completely. They cannot, by themselves, predict antibacterial activity. Engineering studies have generated numerous daptomycin-related compounds and evaluated their antibacterial properties, providing an experimental route for investigating structure–activity relationships beyond residue count alone [4].

4.4. Relationship to established antibacterial biology

Daptomycin’s antibacterial activity has experimentally supported explanations involving calcium-dependent interactions with bacterial-envelope components. Grein and colleagues demonstrated targeting of undecaprenyl-linked cell-wall precursors through a complex involving daptomycin and phosphatidylglycerol [6]. More recently, Buttress and colleagues reported separable activities involving cell-wall precursor targeting and membrane depolarization that did not require those precursors [7].

These results provide mechanistic context, not evidence that the observed numerical correspondences cause antibacterial activity. The mass examined here is that of the parent drug, not the entire calcium-associated, membrane-bound active assembly.

Clinical interpretation likewise remains separate from the numerical analysis. The randomized evidence supports daptomycin’s therapeutic role in the infections studied [1], while pulmonary-surfactant inhibition illustrates why its activity cannot be generalized to every infected tissue; daptomycin is not indicated for pneumonia [2,8]. Neither a Fibonacci count nor mass proximity to \(\varphi\) supplies a treatment-selection criterion.

5. A Framework for Systematic Evaluation

A comparative study could test whether these observations are unusually frequent among peptide antibiotics. The following design is proposed; it has not been carried out in this paper.

Define the population independently of the numerical findings. An initial study could include structurally resolved nonribosomal cyclic lipopeptides selected through a documented database query. Natural products and engineered analogues should be distinguished. Multiple names, formulations, salts, and records of the same compound should not inflate the sample. Closely related analogues should be identified so that a large analogue series is not treated as a large collection of independent molecular families.

Specify the endpoints before examining a validation dataset. Exact Fibonacci membership of total residue count and continuous distance between the average-mass significand and \(\varphi\) are distinct endpoints. The unit convention, mass convention, eligible residue-count range, and any threshold for declaring proximity should be fixed in advance. Adding other number sequences, multiples, partitions, or target constants after inspecting results would enlarge the search space and require corresponding treatment of multiplicity.

Construct chemically appropriate comparisons. A model for residue-count enrichment must allow lengths to vary according to a justified background distribution. Uniform sampling of arbitrary integers is not automatically a biological null model. For the mass endpoint, comparisons should account for residue number, residue composition, lipid-chain length, and cyclization chemistry. A conditional analysis within similar length classes could test whether mass proximity adds information beyond peptide size. Any combined endpoint must preserve the dependence between length and mass.

Separate prediction from explanation. The strongest next step would be successful prediction in a held-out set of compounds or molecular families. Comparisons with prespecified alternative targets could test whether \(\varphi\) is distinctive rather than one of many constants that can be approximated. Even confirmed numerical enrichment would not, by itself, establish causation. Mechanistic claims would additionally require a model predicting how the relevant chemical features influence biosynthesis, stability, membrane interactions, or biological activity.

6. Conclusion

Daptomycin exhibits two clearly defined numerical correspondences: its 13 amino acid residues constitute an exact Fibonacci number, and the decimal significand of its reported average molar mass differs from the golden ratio by approximately 0.163%. A monoisotopic-mass sensitivity calculation also yields proximity, with a deviation of approximately 0.104%.

The exact counting result and approximate mass comparison should remain distinct. Daptomycin’s actual structural partition is \(10+3\), its biosynthetic module partition is \(5+6+2\), and neither has been shown here to arise from a Fibonacci recurrence. The observations nevertheless provide a reproducible starting point for a carefully controlled comparative investigation. Their broader significance depends on independent validation and explanatory evidence, not numerical proximity alone.

References

1. Fowler, V. G. Jr, Boucher, H. W., Corey, G. R. et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. New England Journal of Medicine 355, 653–665 (2006). doi:10.1056/NEJMoa053783.

2. U.S. Food and Drug Administration. Daptomycin for Injection: Prescribing Information. NDA 217415, supplement 003 (2025). Section 11, Description, p. 19; Sections 1.2–1.4, Indications and Limitations of Use. FDA Reference ID 5524896.

3. Miao, V., Coëffet-LeGal, M.-F., Brian, P. et al. Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry. Microbiology 151, 1507–1523 (2005). doi:10.1099/mic.0.27757-0.

4. Nguyen, K. T., Ritz, D., Gu, J.-Q. et al. Combinatorial biosynthesis of novel antibiotics related to daptomycin. Proceedings of the National Academy of Sciences USA 103, 17462–17467 (2006). doi:10.1073/pnas.0608589103.

5. National Center for Biotechnology Information. PubChem Compound Summary for CID 21585658: Daptomycin. Computed monoisotopic mass, 1619.71036639 Da. Accessed 11 October 2026.

6. Grein, F., Müller, A., Scherer, K. M. et al. Ca²⁺-Daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-coupled intermediates and membrane lipids. Nature Communications 11, 1455 (2020). doi:10.1038/s41467-020-15257-1.

7. Buttress, J. A., Schäfer, A.-B., Koh, A. et al. The last resort antibiotic daptomycin exhibits two independent antibacterial mechanisms of action. Nature Communications 16, 10320 (2025). doi:10.1038/s41467-025-65287-w.

8. Silverman, J. A., Mortin, L. I., Vanpraagh, A. D. G., Li, T. & Alder, J. Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact. Journal of Infectious Diseases 191, 2149–2152 (2005). doi:10.1086/430352.